RT @drdavidliew: Secukinumab in GCA, phase 2 (TitAIN): I can't deny this is promising, but phase 2 needs to be interest
Tweet Content
Secukinumab in GCA, phase 2 (TitAIN):
I can't deny this is promising, but phase 2 needs to be
interesting both arms did worse than equivalents in GiACTA, TCZ phase 2 (?looser flare def)
@drpnash: "Bring on the phase 3 trials"
(recruitment startedđź‘€)
#ACR21 ABSTL19 @RheumNow https://t.co/25OAL9BqIZ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off